Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-12-22
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SightGlass Vision Test Arm 1
Single vision, impact-resistant spectacle lenses
Novel spectacle lens design
Use of lenses may reduce the rate of progression of juvenile myopia
SightGlass Vision Test Arm 2
Single vision, impact-resistant spectacle lenses
Spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Novel spectacle lens design
Use of lenses may reduce the rate of progression of juvenile myopia
Spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is 7-14 years of age, inclusive
* Requires spherical spectacle lenses within the power range available for the study lenses
* Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent
* Is willing and able to follow instructions and maintain the appointment schedule
* Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
* Has had a self-reported oculo-visual examination in the last two years
* Spectacle cylinder of ≤ -0.75DC in both eyes
Exclusion Criteria
* Is unable to complete the necessary study activities
* Has any systemic disease affecting ocular health
* Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
* Is aphakic
7 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SightGlass Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Bloomington, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pete S Kollbaum, OD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPRO-2507-002
Identifier Type: -
Identifier Source: org_study_id